Santen
  • Patients
  • Healthcare Professionals
Santen Corporate (EN)
  • Who We Are
    Who We Are
    Menu Top
    Who We Are
    • Message from the CEO
      Who We Are
      Message from the CEO
    • Santen’s Corporate Philosophy Framework
      Who We Are
      Santen’s Corporate Philosophy Framework
    • History of Santen
      Who We Are
      History of Santen
    • Corporate Executives
      Who We Are
      Corporate Executives
    • Corporate Governance
      Who We Are
      Corporate Governance
    • Digital Transformation
      Who We Are
      Digital Transformation
    • Policies and Statements
      Who We Are
      Policies and Statements
    • Overview / Map
      Who We Are
      Overview / Map
    • Global Operations
      Who We Are
      Global Operations
  • What We Do
    What We Do
    Menu Top
    What We Do
    • Medium-Term Management Plan
      What We Do
      Medium-Term Management Plan
    • Efforts to Enhance Patients’ Satisfaction
      What We Do
      Efforts to Enhance Patients’ Satisfaction
      • Efforts to Enhance Product Usability
        Efforts to Enhance Patients’ Satisfaction
        Efforts to Enhance Product Usability
      • Efforts to Address Untreated Patients
        Efforts to Enhance Patients’ Satisfaction
        Efforts to Address Untreated Patients
    • Research & Development
      What We Do
      Research & Development
      • The Ophthalmic Development Process
        Research & Development
        The Ophthalmic Development Process
      • Clinical Trial Information
        Research & Development
        Clinical Trial Information
    • Production and Quality Assurance
      What We Do
      Production and Quality Assurance
      • Production
        Production and Quality Assurance
        Production
      • Safety and Quality Assurance
        Production and Quality Assurance
        Safety and Quality Assurance
      • The Ophthalmic Production Process
        Production and Quality Assurance
        The Ophthalmic Production Process
    • Partnering
      What We Do
      Partnering
      • Santen's Partnership
        Partnering
        Santen's Partnership
      • Our Partners
        Partnering
        Our Partners
      • Partnering Contact
        Partnering
        Partnering Contact
  • Sustainability
    Sustainability
    Menu Top
    Sustainability
    • Sustainability at Santen
      Sustainability
      Sustainability at Santen
    • Environment​
      Sustainability
      Environment​
    • Social
      Sustainability
      Social
    • Governance
      Sustainability
      Governance
    • Sustainability Library
      Sustainability
      Sustainability Library
  • Investor Relations
    Investor Relations
    Menu Top
    Investor Relations
    • Company Information
      Investor Relations
      Company Information
      • Message from the CEO
        Company Information
        Message from the CEO
      • Santen’s Corporate Philosophy Framework
        Company Information
        Santen’s Corporate Philosophy Framework
      • Medium-Term Management Plan
        Company Information
        Medium-Term Management Plan
      • Corporate Governance
        Company Information
        Corporate Governance
      • Corporate Executives
        Company Information
        Corporate Executives
      • Forward-Looking Statement
        Company Information
        Forward-Looking Statement
    • Sustainability
      Investor Relations
      Sustainability
      • Sustainability at Santen
        Sustainability
        Sustainability at Santen
      • Environment​
        Sustainability
        Environment​
      • Social
        Sustainability
        Social
      • Governance
        Sustainability
        Governance
      • Library
        Sustainability
        Library
      • Sustainability Report
        Sustainability
        Sustainability Report
    • IR Library
      Investor Relations
      IR Library
      • Latest IR Documents
        IR Library
        Latest IR Documents
      • Consolidated Performance
        IR Library
        Consolidated Performance
      • Presentation Materials・Videos
        IR Library
        Presentation Materials・Videos
      • Integrated Report (Annual Report)
        IR Library
        Integrated Report (Annual Report)
      • Data Book
        IR Library
        Data Book
      • Pipeline
        IR Library
        Pipeline
      • Accounting Standards and Definition of "Core Basis"
        IR Library
        Accounting Standards and Definition of "Core Basis"
    • Stock Information
      Investor Relations
      Stock Information
      • Stock Information
        Stock Information
        Stock Information
      • Materials for the General Meeting of Shareholders
        Stock Information
        Materials for the General Meeting of Shareholders
      • Distribution of Profits to Shareholders and Dividends
        Stock Information
        Distribution of Profits to Shareholders and Dividends
      • IR Calendar
        Stock Information
        IR Calendar
      • Analyst Coverage
        Stock Information
        Analyst Coverage
    • Innovation
      Investor Relations
      Innovation
      • Efforts to Enhance Patients' Satisfaction
        Innovation
        Efforts to Enhance Patients' Satisfaction
      • Research and Development
        Innovation
        Research and Development
      • Production
        Innovation
        Production
      • Safety and Quality Assurance
        Innovation
        Safety and Quality Assurance
  • Careers
    Careers
    Menu Top
    Careers
  • Our Stories
    Our Stories
    Menu Top
    Our Stories
  • News
    News
    Menu Top
    News
  1. Home
  2. Investors Relations
  3. Latest IR Documents
  4. Presentation Materials·Videos
  5. Investor Meeting First Half Results; six months ended Sep 30, 2004

Investor Meeting First Half Results; six months ended Sep 30, 2004

Takakazu Morita
President and CEO
  • Summary of the first six months ended september 30, 2004; Forecasts for the Year ending March 2005; and Progress of the Medium-term Management Plan (PDF: 38KB)PDF file.Page will open in a new window.
Ichiro Otokozawa
Senior Corporate Officer
Head of Corporate Development and Administration Division
  • Consolidated Financial Results for the first six months ended september 30, 2004 and Consolidated Financial Forecasts for the Year ending March 2005 (PDF: 137KB)PDF file.Page will open in a new window.
Toshiaki Nishihata, Ph.D.
Senior Corporate Officer
Head of Research and Development Division
  • Status of Clinical Development (PDF: 38KB)PDF file.Page will open in a new window.
Santen

Official Social Media Accounts

LinkedIn YouTube
  • Who We Are
    • Message from the CEO
    • Santen’s Corporate Philosophy Framework
    • History of Santen
    • Corporate Executives
    • Corporate Governance
    • Digital Transformation
    • Policies and Statements
    • Overview / Map
    • Global Operations
  • What We Do
    • Medium-term Management Plan
    • Efforts to Enhance Patients’ Satisfaction
    • Research & Development
    • The Ophthalmic Development Process
    • Clinical Trial Information
    • Santen's Partnership
    • Production
    • Safety and Quality Assurance
    • The Ophthalmic Production Process
  • Sustainability
    • Sustainability at Santen
    • Environment​
    • Social
    • Governance
    • Sustainability Library
  • Investor Relations
    • Latest IR Documents
    • Stock Information
    • Materials for the General Meeting of Shareholders
    • Distribution of Profits to Shareholders and Dividends
    • IR Calendar
    • Analyst Coverage
  • Careers
  • Our Stories
  • News
  • Contact
Santen Global
  • Terms of Use
  • Privacy Policy
© Santen Pharmaceutical Co., Ltd.
All Rights Reserved